+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sickle Cell Syndromes, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine Volume 36-6

  • Book

  • November 2022
  • Region: North America
  • Elsevier Health Science
  • ID: 5694290
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy: reproductive health; chronic pain; and more.
  • Contains 16 relevant, practice-oriented topics including innovative therapies, addressing challenging complications, novel science on mechanisms of disease; preventing cognitive decline in people with SCD; quality of life in SCD; and more.

  • Provides in-depth clinical reviews on sickle cell syndromes, offering actionable insights for clinical practice.

  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Structural Racism and Impact on Sickle Cell Disease: Sickle Cell Lives MatterSickle Cell Disease Pathophysiology and Related Molecular and Biophysical BiomarkersGenetic Modifiers of Sickle Cell DiseaseEconomics of Sickle Cell Disease and Evidence to Support Comprehensive CareQuality of Life in Sickle Cell Disease: What MattersChronic Pain: Prevalence and ManagementThe Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell DiseaseClinical Vignettes Part IClinical Vignettes Part IIThe Cardiopulmonary Complications of Sickle Cell DiseaseSickle Cell Disease and the Kidney: Filters Gone AwryGo the Distance: Reproductive Health Care for People with Sickle Cell DiseaseGenotyping and the Future of Transfusion in Sickle Cell DiseaseThe Evolving Landscape of Drug Therapies for Sickle Cell DiseaseAllogeneic Transplant and Gene Therapy: Evolving Toward a Cure

Authors

Sophie Lanzkron Professor of Medicine. Jane Little Professor of Medicine, University of North Carolina at Chapel Hill.